Hepatorenal syndrome in cirrhotic patients: terlipressine is a safe and efficient treatment; propranolol and digitalic treatments: precipitating and preventing factors?

Suppr

超能文献

作者信息

Duhamel C, Mauillon J, Berkelmans I, Bourienne A, Tranvouez J L

出版信息

Am J Gastroenterol. 2000 Oct;95(10):2984-5. doi: 10.1111/j.1572-0241.2000.03214.x.

DOI:10.1111/j.1572-0241.2000.03214.x

PMID:11051385

Abstract

摘要

相似文献

Hepatorenal syndrome in cirrhotic patients: terlipressine is a safe and efficient treatment; propranolol and digitalic treatments: precipitating and preventing factors?

Am J Gastroenterol. 2000 Oct;95(10):2984-5. doi: 10.1111/j.1572-0241.2000.03214.x.

Terlipressin. Type I hepatorenal syndrome: an extra window of time before liver transplantation.特利加压素。I型肝肾综合征：肝移植前的额外时间窗口。

Prescrire Int. 2006 Dec;15(86):220.

Long-term treatment of hepatorenal syndrome as a bridge to liver transplantation.肝肾综合征的长期治疗作为肝移植的桥梁。

Dig Liver Dis. 2011 Mar;43(3):242-5. doi: 10.1016/j.dld.2010.08.001. Epub 2010 Sep 15.

Terlipressin and albumin combination treatment in hepatorenal syndrome.特利加压素与白蛋白联合治疗肝肾综合征

Hepatogastroenterology. 2003 Dec;50 Suppl 2:ccciii-cccv.

Noradrenalin vs terlipressin in patients with hepatorenal syndrome: a prospective, randomized, unblinded, pilot study.去甲肾上腺素与特利加压素治疗肝肾综合征患者的前瞻性、随机、非盲、试点研究。

J Hepatol. 2007 Oct;47(4):499-505. doi: 10.1016/j.jhep.2007.04.010. Epub 2007 May 24.

Terlipressin therapy for reversal of type 1 hepatorenal syndrome: a meta-analysis of randomized controlled trials.特利加压素治疗 1 型肝肾综合征逆转：随机对照试验的荟萃分析。

J Gastroenterol Hepatol. 2010 May;25(5):880-5. doi: 10.1111/j.1440-1746.2009.06132.x. Epub 2010 Jan 14.

Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study.特利加压素联合白蛋白与白蛋白治疗肝硬化合并肝肾综合征患者的随机研究

Gastroenterology. 2008 May;134(5):1352-9. doi: 10.1053/j.gastro.2008.02.024. Epub 2008 Feb 14.

Terlipressin may influence the outcome of hepatorenal syndrome complicating alcoholic hepatitis.特利加压素可能会影响并发酒精性肝炎的肝肾综合征的预后。

Am J Gastroenterol. 1997 Nov;92(11):2113-4.

[Vasoconstrictors in the treatment of hepatorenal syndrome].[血管收缩剂在肝肾综合征治疗中的应用]

Nefrologia. 2002;22 Suppl 5:56-61.

Hepatorenal syndrome after treatment of visceral leishmaniasis requiring terlipressin therapy.内脏利什曼病治疗后出现肝肾综合征，需要特利加压素治疗。

Minerva Gastroenterol Dietol. 2015 Sep;61(3):171-2.

引用本文的文献

Treatment for hepatorenal syndrome in people with decompensated liver cirrhosis: a network meta-analysis.失代偿期肝硬化患者肝肾综合征的治疗：一项网状Meta分析。

Cochrane Database Syst Rev. 2019 Sep 12;9(9):CD013103. doi: 10.1002/14651858.CD013103.pub2.

Optimal management of hepatorenal syndrome in patients with cirrhosis.肝硬化患者肝肾综合征的优化管理

Hepat Med. 2010 Jun 21;2:87-98. doi: 10.2147/hmer.s6918.

Hepatorenal syndrome.肝肾综合征。

World J Gastroenterol. 2012 Sep 28;18(36):4978-84. doi: 10.3748/wjg.v18.i36.4978.

Therapeutic response to vasoconstrictors in hepatorenal syndrome parallels increase in mean arterial pressure: a pooled analysis of clinical trials.肝肾综合征中血管收缩剂治疗反应与平均动脉压升高呈正相关：临床试验的汇总分析。

Am J Kidney Dis. 2011 Dec;58(6):928-38. doi: 10.1053/j.ajkd.2011.07.017. Epub 2011 Sep 29.

A randomized, prospective, double-blind, placebo-controlled trial of terlipressin for type 1 hepatorenal syndrome.特利加压素治疗1型肝肾综合征的随机、前瞻性、双盲、安慰剂对照试验

Gastroenterology. 2008 May;134(5):1360-8. doi: 10.1053/j.gastro.2008.02.014. Epub 2008 Feb 13.

Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis.肝硬化肝肾综合征的诊断、预防及治疗

Gut. 2007 Sep;56(9):1310-8. doi: 10.1136/gut.2006.107789. Epub 2007 Mar 27.

Octreotide/Midodrine therapy significantly improves renal function and 30-day survival in patients with type 1 hepatorenal syndrome.奥曲肽/米多君疗法显著改善1型肝肾综合征患者的肾功能及30天生存率。

Dig Dis Sci. 2007 Mar;52(3):742-8. doi: 10.1007/s10620-006-9312-0.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验